Repare Therapeutics Inc. Restructuring Costs
Repare Therapeutics Inc. reported Restructuring Costs of $1.80 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2025-11-14
- Repare Therapeutics Inc. restructuring costs for the quarter ending 2025-09-30 was $1.80M, a 20.00% increase year-over-year.
- Repare Therapeutics Inc. restructuring costs for the quarter ending 2025-06-30 was $3.40M.
- Repare Therapeutics Inc. restructuring costs for the quarter ending 2025-03-31 was $3.30M.
- Repare Therapeutics Inc. restructuring costs for the quarter ending 2024-12-31 was -$100.00K.
- Repare Therapeutics Inc. restructuring costs for fiscal 2024 was $1.40M.
- Repare Therapeutics Inc. restructuring costs for fiscal 2023 was $0.00.
| Period end | Restructuring Costs 3 month | Restructuring Costs 6 month | Restructuring Costs 9 month | Restructuring Costs 12 month |
|---|---|---|---|---|
| 2025-09-30 | $1.80M 10-Q · filed 2025-11-14 | $5.20M derived: sum of 2 quarters · filed 2025-11-14 | $8.50M 10-Q · filed 2025-11-14 | $8.40M derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-06-30 | $3.40M 10-Q · filed 2025-08-08 | $6.60M 10-Q · filed 2025-08-08 | $6.60M derived: sum of 3 quarters · filed 2025-08-08 | $8.10M derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-03-31 | $3.30M 10-Q · filed 2025-05-13 | $3.20M derived: sum of 2 quarters · filed 2025-05-13 | $4.70M derived: sum of 3 quarters · filed 2025-11-14 | $4.70M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $1.40M derived: sum of 2 quarters · filed 2025-11-14 | $1.40M derived: sum of 3 quarters · filed 2025-11-14 | $1.40M 10-K · filed 2025-03-03 |
| 2024-09-30 | $1.50M 10-Q · filed 2025-11-14 | $1.50M derived: sum of 2 quarters · filed 2025-11-14 | $1.50M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-08 | $0.00 10-Q · filed 2025-08-08 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-03-03 |